Skip to main content

Table 2 Schedule of visits and assessment

From: Could enteral nutrition improve the outcome of patients with haematological malignancies undergoing allogeneic haematopoietic stem cell transplantation? A study protocol for a randomized controlled trial (the NEPHA study)

  Time point
D-14 to D-7 D1 D7 D14 D21 D28 D60 D90 D180 D270 D360
Informed consent x           
Allocation x           
Energetic and caloric needs assessment    x x x -------------------------------------➔ 1
Digestive symptoms and tolerance (individual notebook)   x --------------------------------------------------------- ➔ 2
Functional status (Performance status, sit-up test, dynamometry, Weight, body-mass index, brachial circumference) x    x   x x x x   x
Hepatic tolerance (Total bilirubin, free and conjugated bilirubin, AST, ALT, ALP, GGT) x   x x x x x x x x x
Transthyretin, C-reactive protein x   x x x -------------------------------------➔ 3
Albumin x      x x x x   x
Clinical assessment (GVHD, mucositis, infectious complications, red blood cells and platelets transfusions, catheter complications)    x x x x x x x x x
Chimerism       x x x x   x
Quality of life (QLQ-C30) x        x x   x
  1. 1Evaluated until hospital discharge; 2Auto-evaluated daily during nutritional intervention; 3Evaluated once per week until hospital discharge; ALP: alkaline phosphatase; ALT: alanine aminotransferase; AST: aspartate aminotransferase; GGT: gamma-glutamyltransferase.